NTRK fusion as therapeutic target for treatment of central nervous system tumors — current data and perspectives

Neurotrophic tyrosine receptor kinase (NTRK) gene fusion represents a rare but highly significant oncogenicmolecular aberration with a predictive role in cancer therapy. Despite its low incidence, it is found in numeroustumors, including primary and metastatic central nervous system (CNS) tumors. It...

Cijeli opis

Bibliografski detalji

Glavni autori:	Julia Piekarz, Natalia Picheta, Jakub Pobideł, Katarzyna Szklener
Format:	Artigo
Jezik:	Inglês
Izdano:	Via Medica 2026-10-01
Serija:	Oncology in Clinical Practice
Teme:	NTRK gene fusions TRK inhibitors primary brain tumors brain metastases NTRK fusion-positive brain tumors
Online pristup:	https://journals.viamedica.pl/oncology_in_clinical_practice/article/view/107663
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!